Shanghai Gusen Pharmaceutical

Shanghai Gusen Pharmaceutical is a biopharmaceutical company specializing in the development and industrialization of high-end inhalation drug delivery systems. The company focuses on respiratory diseases, particularly asthma and chronic obstructive pulmonary disease (COPD), by integrating advanced formulation science with proprietary inhalation device engineering. Its technology portfolio includes dry powder inhalers (DPI), metered-dose inhalers (MDI), and nebulized formulations. Gusen's pipeline consists of complex generic versions of major respiratory blockbusters as well as innovative proprietary drug candidates. Based in Shanghai's Zhangjiang Hi-Tech Park, the company aims to provide high-quality, affordable respiratory treatments for both domestic and international markets.